Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Applied Therapeutics Inc
(NQ:
APLT
)
5.770
+0.170 (+3.04%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Applied Therapeutics Inc
< Previous
1
2
3
4
5
6
Next >
Applied Therapeutics Announces Positive Sorbitol Reduction Data From the Ongoing Phase 3 INSPIRE Trial in Sorbitol Dehydrogenase (SORD) Deficiency
February 16, 2023
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics to Present at the SVB Securities Global Biopharma Conference
February 09, 2023
From
Applied Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
January 31, 2023
Via
Benzinga
Recap: Applied Therapeutics Q2 Earnings
August 12, 2022
Applied Therapeutics (NASDAQ:APLT) reported its Q2 earnings results on Friday, August 12, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Why Applied Therapeutics Shares Are Seeing Blue Skies
January 04, 2023
Applied Therapeutics Inc (NASDAQ: APLT) shares are trading higher by 15.99% to $0.87 Wednesday morning after the company announced a partnership with Advanz Pharma for the commercialization of AT-007...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
January 04, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
January 04, 2023
We're starting off the day with a breakdown of the biggest pre-market stock movers traders need to know about on Wednesday!
Via
InvestorPlace
Applied Therapeutics Announces Partnership with Advanz Pharma for Commercialization of AT-007 (Govorestat) in Europe
January 04, 2023
From
Applied Therapeutics
Via
GlobeNewswire
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 30, 2022
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 29, 2022
Via
Benzinga
Applied Therapeutics Reports Third Quarter 2022 Financial Results
November 09, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Multiple Data Presentations at the American Heart Association Scientific Sessions November 5-7, 2022
October 31, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Applied Therapeutics Announces Full Enrollment in the Registrational Phase 3 ARISE-HF Trial of AT-001 in Diabetic Cardiomyopathy
October 25, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Helbiz And 3 Other Stocks Under $1 Insiders Are Aggressively Buying
October 17, 2022
The Dow Jones dropped by more than 400 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
Why Morgan Stanley Shares Are Trading Lower, Here Are 43 Stocks Moving In Friday's Mid-Day Session
October 14, 2022
Gainers Intelligent Living Application Group Inc. (NASDAQ: ILAG) surged 77.7% to $9.35.
Via
Benzinga
Why Laser Photonics Shares Surged By Around 19%; Here Are 70 Biggest Movers From Friday
October 17, 2022
Gainers Agrify Corporation (NASDAQ: AGFY) climbed 53.8% to close at $1.45. FedNat Holding Company (NASDAQ: FNHC) gained 48% to settle at $0.52.
Via
Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
October 06, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 06, 2022
Gainers
Via
Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Nasdaq Edges Higher; AngioDynamics Shares Plummet
October 06, 2022
U.S. stocks pared losses midway through trading, with the Nasdaq Composite turning higher on Thursday.
Via
Benzinga
Applied Therapeutics' Lead Candidate Pediatric Study Failed To Reach Statistical Significance
October 06, 2022
Applied Therapeutics Inc's (NASDAQ: APLT) ACTION-Galactosemia Kids Phase 3 trial has demonstrated a trend in clinical benefit favoring AT-007 vs. placebo.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 06, 2022
Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.
Via
Benzinga
Applied Therapeutics Announces Positive Data Trend in AT-007 ACTION-Galactosemia Kids Pediatric Trial; Trial Will Continue to 18 Months in Blinded Format
October 06, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
August 18, 2022
It's time to take a look at the biggest pre-market stock movers for Thursday and the news that's got those shares moving!
Via
InvestorPlace
TransDigm Group To $740? Also Check Out Some Other Major PT Changes
August 16, 2022
Wells Fargo raised the price target on TransDigm Group Incorporated (NYSE: TDG) from $620 to $740. Wells Fargo analyst Matthew Akers maintained an Overweight rating on the stock. TransDigm Group shares...
Via
Benzinga
Applied Therapeutics to Sponsor and Present at the 2022 Galactosemia Foundation Conference
July 28, 2022
From
Applied Therapeutics
Via
GlobeNewswire
Aspen Aerogels And 28 Stocks Moving Premarket
June 30, 2022
Gainers
Via
Benzinga
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
July 01, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase...
Via
Benzinga
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
June 30, 2022
Gainers Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.